Stay updated on Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Sign up to get notified when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, and the previous maintenance notice (Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T04:55:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, and the page now shows Revision: v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:36:46.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The changes are cosmetic/UI and metadata updates: the glossary toggle is shown, the capitalization of 'Met QC Criteria' is adjusted, the No FEAR Act data label is updated, and the revision/version is updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:07:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T02:26:52.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new Locations section was added listing study sites in Minnesota, New Jersey, New York, Pennsylvania, and Utah, and state-specific location subsections were removed. The page revision updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T21:36:17.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed, and updated the page revision to v3.3.2 (replacing the previous v3.2.0 wording). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:45:23.000Z thumbnail image

Stay in the know with updates to Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.